yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34554492-6976BECC-F565-4C2A-ADDA-6C10044E6DA5
Q34554492-6976BECC-F565-4C2A-ADDA-6C10044E6DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34554492-6976BECC-F565-4C2A-ADDA-6C10044E6DA5
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
P1433
Q34554492-6976BECC-F565-4C2A-ADDA-6C10044E6DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34554492-6976BECC-F565-4C2A-ADDA-6C10044E6DA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e77e8b6a199ebfcc847acba22f83c8bc404c62be
P1433
British Journal of Clinical Pharmacology